Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Lung cancer is hard to catch early and even harder to survive once it is found. A new clinical trial will test whether a ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

A groundbreaking lung cancer vaccine will be tested on humans from summer 2026, with British scientists working on jabs for ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...

Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcutaneous (under the skin) injections of programmed death ligand 1 (PD-L1) blocker called ...

The study showed that women who received at least one dose of the quadrivalent HPV vaccine had a 37 per cent lower incidence ...

Becomes available free of charge for nine-year-old girls at EPI centres; other provinces expected to follow suit.